个人简介
Roberto Lanzi医生是圣拉斐尔科学研究医院内分泌科甲状腺(腺体)功能诊断部门的负责人,在Andrea Giustina教授的指导下开展工作。
1987年,毕业于米兰大学医学院。1992年获得内科专业学位,1996年获得内分泌科专业学位。在研究期间,Lanzi医生在加拿大魁北克蒙特利尔麦吉尔大学蒙特利尔儿童医院研究所神经肽生理学实验室担任研究员。
在临床活动中,Lanzi医生专注于内分泌疾病,特别是垂体、肾上腺和甲状腺功能障碍。此外,他还进行了超声和甲状腺细胞学诊断。
自2018年以来,Lanzi医生为引入射频疗法治疗良性甲状腺结节做出了贡献。他与甲状腺肿瘤学多学科诊所合作。此外,他是圣拉斐尔科学研究医院生育中心的顾问及内分泌科医生。
自2010年以来,Lanzi医生是日间内科医院的负责人。
Lanzi医生是圣拉斐尔科学研究医院罕见病区域网络和欧洲网络Endo-ERN成人内分泌系统罕见病的指导人。
Lanzi医生是多个科学学会的成员,包括内分泌学会、意大利内分泌学会(SIE)、内分泌学家协会(AME)、意大利医学和生物学超声学会(SIUMB)、国际毛发研究基金会(IHRF)。
他是内分泌学领域国际学术期刊发表的60篇论文和8个书籍章节的作者。
教育背景
University of Milan
Degree in Medicine and Surgery - 1987
University of Milan
Specialization in Internal Medicine - 1992
University of Milan
Specialization in Experimental Endocrinology - 1996
出版物
最新出版物
Time course and mechanism of growth hormone's negative feedback effect on its own spontaneous release
Endocrinology, 1992, 130: 780-788.
扩展阅读
Time-dependent reduction and potentiation of GH responsiveness to GH-releasing factor induced by exogenous GH; role for somatostatin.
Endocrinology, 1992, 130: 1822-1828.
扩展阅读
Evidence of a primary role for somatostatin in mediating clonidine-induced growth hormone release in conscious rats.
J. Endocrinol., 1994, 141: 259-266.
扩展阅读
Growth hormone (GH) metabolic clearance rate, half life and volume of distribution in acromegalic patients: assessment by combined GH and octreotide infusions.
J. Clin. Endocrinol. Metab., 1995, 80: 3279-3283.
扩展阅读
Restoration of growth hormone (GH) response to GHreleasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Clin. Endocrinol. Metab., 1996, 81: 3998-4001
扩展阅读
Evidence for an inhibitory effect of physiological levels of insulin on the growth hormone(GH) response to GH-releasing hormone (GHRH) in healthy subjects.
J. Clin. Endocrinol. Metab.,1997, 82: 2239-2243.
扩展阅读
Laparoscopic bilateral adrenalectomy for persistent Cushing’s disease after transsphenoidal surgery.
Surgery, 1998, 123: 144-150.
扩展阅读
The control on growth hormone (GH) release by free fatty acids is maintained in acromegaly.
Endocrinol: Metab., 1999, 84 (4): 1234-1238
扩展阅读
Elevated insulin levels contribute to the reduced growth hormone (GH) response to GH-releasing hormone in obese subjects.
Metabolism, 1999, 48 (9): 1152-1156.
扩展阅读
GH replacement therapy increases blood osteoprotegerin levels in GH deficient adults.
European Journal of Endocrinology, 2003, 148: 185-191.
扩展阅读
Long-term effects of growth hormone replacement therapy on thyroid function in adults with growth hormone deficiency.
Thyroid, 2008, 18 (12):1249-54.
扩展阅读
Treatment of thyroid-associated orbithopathy with Rituximab: a novel therapy for an old disease. Case report and literature review.
Endocr. Pract., 2010, 16 (4): 677-685
扩展阅读
Magnetic Resonance Imaging with Diffusion Weighted Imaging in the evaluation of Thyroid-Associated Orbitopathy: getting below the tip of the iceberg.
European Radiol, 2014, Eur Radiol. 2014 May;24(5):1118-26.
扩展阅读
Ovarian hyperstimulation syndrome due to folliclestimulating hormone-secreting pituitary adenomas.
Pituitary 2017, 20 (5): 553-560.
扩展阅读
Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency.
Growth Hormone & IGF Research 2019, 46–47: 50–54
扩展阅读